Loading clinical trials...
Loading clinical trials...
Exploring the Influence of Clinical Factors on the Prognosis of Papillary Renal Cell
Patients with renal cell carcinoma who were admitted to the First Affiliated Hospital of Sun Yat-sen University from February 1, 2021, to February 1, 2022, and met the following inclusion and exclusion criteria were collected. Clinical factors influencing the prognosis of enrolled patients were retrospectively analyzed, and a predictive system was established based on this. (Inclusion criteria: pathology of the surgical specimen confirmed the diagnosis of pRCC,b: age 18 years or older, c: localized RCC underwent radical nephrectomy or partial nephrectomy in our center. Exclusion criteria:a: lack of original CT images, b: patients with malignant tumors of other systems, c: patients who lost follow-up.)
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Start Date
February 1, 2012
Primary Completion Date
February 1, 2022
Completion Date
February 1, 2022
Last Updated
November 1, 2023
160
ACTUAL participants
We do not have any interventions. This study is based on obseravation.
OTHER
Lead Sponsor
Sun Yat-sen University
NCT07227415
NCT05127824
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05865730